Press monitoring
Nanoscientists Create Biological Switch From Spinach Molecule
18.9.2006 | Press monitoring
Nanoscientists have transformed a molecule of chlorophyll-a from spinach into a complex biological switch that has possible future applications for green energy, technology and medicine.
New Generation Of Super Microscopes Poised For Scientific Use
17.9.2006 | Press monitoring
Super-high resolution optical microscopes, with powers that seemed physically impossible a decade ago, are poised to open a new era in imaging in molecular biology, according to a report scheduled for the Sept. 4 issue of Chemical & Engineering News, the ACS' weekly news magazine.
Live H5N1 avian flu virus vaccines show protection in animal studies
16.9.2006 | Press monitoring
When tested in mice and ferrets, experimental vaccines based on live, weakened versions of different strains of the H5N1 avian influenza virus were well-tolerated and protected the animals from a deadly infection with naturally occurring H5N1 flu viruses. The findings, which appear in the September 12 issue of PLoS Medicine, are also encouraging,...
Getting nanowires on the brain
16.9.2006 | Press monitoring
Researchers from Harvard University, US, have linked nanowire field-effect transistors to neurones, cells found in the brain and nervous system that create and transmit electrical signals. As well as offering the potential for hybrid biological/electronic devices and interfaces to neural prosthetics, the technique could provide high-resolution...
Biofuels seen transforming EU farm markets
16.9.2006 | Press monitoring
WESTON-SUPER-MARE (Reuters) - A sharp rise in the use of food crops to produce biofuels will have a big impact on European agricultural markets, John Townend of Arkady Feed UK Ltd said on Wednesday.
Enzymes may hold answer to harnessing hydrogen power
15.9.2006 | Press monitoring
NORWICH (Reuters) - Enzymes rather than scarce and expensive platinum may hold the answer to the hydrogen fuel cells of the future to halt global warming and as the oil runs out, a scientist said on Wednesday.
Anti-inflammatory Drug Prevents Liver Cancer In At-risk Liver Patients
14.9.2006 | Press monitoring
Colchicine, an anti-inflammatory drug most often used to treat gout, prevented liver cancer in patients with hepatitis virus-related end-stage liver disease, according to a new study. Published in the October 15, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study found that over three years of follow-up,...
Ultrasound Delivers Therapeutic Molecules Into Living Cells
14.9.2006 | Press monitoring
Researchers have shown how ultrasound energy can briefly “open a door” in the protective outer membranes of living cells to allow entry of drugs and other therapeutic molecules – and how the cells themselves can then quickly close the door. Understanding this mechanism could advance the use of ultrasound for delivering gene therapies, targeting...
Tuning the body's defence to cancer
13.9.2006 | Press monitoring
Turning off our natural killer could help to reduce chemotherapy side effects.
Nanodoodling shows pipette power
12.9.2006 | Press monitoring
It is highly accurate, but there is something unusual about this image of the Cambridge University crest.
